1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Y 27632: new trials by email Literature Review of Y 27632 trials Research Report on Y 27632
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction Combination Product: AURN001 + Y-27632, Placebo - Corneal Edema, Corneal Endothelial Dysfunction | Phase 3 | Active not recruiting | Aurion Biotech | 130 | 2026-02-19 | 2026-09-24 |
| A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1) AURN001, Corneal Endothelial Cells, Y27632 - Corneal Edema, Corneal Endothelial Dysfunction | Phase 1 / Phase 2 | Completed | Aurion Biotech | 97 | 2023-10-18 | 2025-12-17 |
Corneal Edema (2)
Aurion Biotech (2)
United States (2) · Canada (1)